Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis

Authors
Publication date
1 January 2015
Publisher
Doi
    View on PubMed

    Abstract

    Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and adverse events following rituximab since that time in an inception cohort

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:xd07h156c
      Last time updated on 24/11/2020